Self-monitoring of blood glucose (SMBG) has little impact on HbA1c levels in patients not on insulin therapy 1, 2 At $47.4 million, blood glucose test strips were the third highest expenditure in BC in 2009 for insurable pharmacy dispensed products.
*As glucose test strips are available without a prescription, this portrait shows provincial data rather than your personal prescribing data. Although general practitioners do not usually prescribe test strips, you can help your patients reduce unnecessary testing. 
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SMBG does not lead to clinically significant changes in HbA1c levels in patients not on insulin therapy.
Clinical trials have randomized people (not on insulin)
to SMBG or no SMBG. A meta-analysis showed no clinically significant difference in HbA1c levels between these groups at 6 months 1 and far more importantly, 2 RCTs showed that minimal differences at 6 months were not sustained at 1 year.
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